The lactose intolerance treatment market is projected to grow from $28.38B in 2022 to $30.38B in 2023, at a CAGR of 7.1% and is expected to reach $39.18B in 2027, with a CAGR of 6.6%, according to a report by Research & Markets.
The increasing incidences of small intestine diseases are expected to drive the growth of the lactose intolerance treatment market. Small intestine diseases affect the digestive system and lead to persistent gastrointestinal tract inflammation. Lactose intolerance treatment plays a crucial role in managing these disorders. By providing the necessary lactase enzyme to break down lactose, these treatments alleviate symptoms and promote digestive health.
Product innovation is driving growth in the lactose intolerance treatment market.